Intervention not reported
Cardiovascular mortality · healthy normal weighted participants recruited through leaflets from Italy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiovascular mortality · patients with coronary heart disease
Exercise‐based cardiac rehabilitation showed no clear difference in cardiovascular mortality compared with 'no exercise' control (moderate certainty).
1 finding from 1 review
Cardiovascular mortality · adults after heart valve surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiovascular mortality · patients with chronic heart failure with preserved ejection fraction
Beta‐blockers may leads to lower cardiovascular mortality (RR) compared with placebo or no treatment (low certainty).
1 finding from 1 review
Cardiovascular mortality · patients with chronic heart failure with preserved ejection fraction
Angiotensin‐converting enzyme inhibitors (ACEIs) showed no clear difference in cardiovascular mortality (RR) compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Cardiovascular mortality · patients with chronic heart failure with preserved ejection fraction
Angiotensin receptor blockers (ARBs) showed no clear difference in cardiovascular mortality (RR) compared with placebo or no treatment (high certainty).
1 finding from 1 review
Cardiovascular mortality · patients with chronic heart failure with preserved ejection fraction
Mineralocorticoid receptor antagonists (MRAs) showed no clear difference in cardiovascular mortality (RR) compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Cardiovascular mortality · CVD (ASCVD, HF, or both)
DPP4i showed no clear difference in cardiovascular mortality compared with placebo (high certainty).
1 finding from 1 review
Cardiovascular mortality · CVD (ASCVD, HF, or both)
GLP‐1RA leads to lower cardiovascular mortality compared with placebo (high certainty).
1 finding from 1 review
Cardiovascular mortality · CVD (ASCVD, HF, or both)
SGLT2i probably leads to lower cardiovascular mortality compared with placebo (moderate certainty).
1 finding from 1 review
Cardiovascular mortality · people at any baseline risk of CVD
Effect of reducing saturated fat showed no clear difference in cardiovascular mortality compared with usual saturated fat on CVD risk (moderate certainty).
1 finding from 1 review
Cardiovascular mortality · patients without heart failure
Natriuretic peptide‐guided treatment showed no clear difference in cardiovascular mortality compared with standard care (low certainty).
1 finding from 1 review
Cardiovascular mortality · people with or without existing cardiovascular disease, men and women
Higher polyunsaturated fatty acid (PUFA) showed no clear difference in cardiovascular mortality compared with lower PUFA (low certainty).
1 finding from 1 review
Intervention not reported
Cardiovascular mortality · people with cardiovascular disease or at high risk of cardiovascular disease
The intervention showed no clear difference in cardiovascular mortality (moderate certainty).
1 finding from 1 review
Cardiovascular mortality · people with coronary disease, ischaemic cerebrovascular disease, peripheral arterial disease or at high risk of atherothrombotic disease
clopidogrel plus aspirin showed no clear difference in cardiovascular mortality compared with aspirin alone (moderate certainty).
1 finding from 1 review
Intervention not reported
Cardiovascular mortality ( · people with or at risk of cardiovascular disease
The intervention showed no clear difference in cardiovascular mortality ( (moderate certainty).
1 finding from 1 review
Cardiovascular mortality · patients with stable angina pectoris
Ranolazine (monotherapy) showed no clear difference in cardiovascular mortality compared with placebo (low certainty).
1 finding from 1 review
Intervention not reported
Cardiovascular mortality · people with hyperlipidaemia
1 finding from 1 review
Cardiovascular mortality · any patient population and people with high cardiovascular risk
Colchicine showed no clear difference in mortality (cardiovascular) compared with any control treatment (moderate certainty).
1 finding from 1 review
Intervention not reported
Total cardiovascular mortality · Free‐living adults who were healthy, had established cardiovascular disease or risk factors for cardiovascular disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found